These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26612044)

  • 21. Economics of Community Health Workers for Chronic Disease: Findings From Community Guide Systematic Reviews.
    Jacob V; Chattopadhyay SK; Hopkins DP; Reynolds JA; Xiong KZ; Jones CD; Rodriguez BJ; Proia KK; Pronk NP; Clymer JM; Goetzel RZ
    Am J Prev Med; 2019 Mar; 56(3):e95-e106. PubMed ID: 30777167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular disease (CVD) and associated risk factors among older adults in six low-and middle-income countries: results from SAGE Wave 1.
    Ruan Y; Guo Y; Zheng Y; Huang Z; Sun S; Kowal P; Shi Y; Wu F
    BMC Public Health; 2018 Jun; 18(1):778. PubMed ID: 29925336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in Israel.
    Melzer Cohen C; Hallén N; Chodick G; Bourvine L; Waner T; Karasik A
    Value Health Reg Issues; 2020 Sep; 22():83-92. PubMed ID: 32798839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of the effectiveness of transport sector interventions in low- and middle-income countries: An evidence and gap map.
    Malhotra SK; White H; Dela Cruz NAO; Saran A; Eyers J; John D; Beveridge E; Blöndal N
    Campbell Syst Rev; 2021 Dec; 17(4):e1203. PubMed ID: 36951810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costs, benefits, and effectiveness of interventions for the prevention, treatment, and control of cardiovascular diseases and diabetes in Africa.
    Mendis S; Chestnov O
    Prog Cardiovasc Dis; 2013; 56(3):314-21. PubMed ID: 24267438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease.
    Mehta S; Ghosh S; Sander S; Kuti E; Mountford WK
    J Manag Care Spec Pharm; 2018 Mar; 24(3):280-290. PubMed ID: 29485954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
    Dunbar SB; Khavjou OA; Bakas T; Hunt G; Kirch RA; Leib AR; Morrison RS; Poehler DC; Roger VL; Whitsel LP;
    Circulation; 2018 May; 137(19):e558-e577. PubMed ID: 29632217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation and Prediction of Avoidable Health Care Costs of Cardiovascular Diseases and Type 2 Diabetes Through Adequate Dairy Food Consumption: A Systematic Review and Micro Simulation Modeling Study.
    Javanbakht M; Jamshidi AR; Baradaran HR; Mohammadi Z; Mashayekhi A; Shokraneh F; Rezai Hamami M; Yazdani Bakhsh R; Shabaninejad H; Delavari S; Tehrani A
    Arch Iran Med; 2018 May; 21(5):213-222. PubMed ID: 29738265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical dietary interventions to prevent cardiovascular disease suitable for implementation in primary care: an ADAPTE-guided systematic review of international clinical guidelines.
    Le Goff D; Aerts N; Odorico M; Guillou-Landreat M; Perraud G; Bastiaens H; Musinguzi G; Le Reste JY; Barais M
    Int J Behav Nutr Phys Act; 2023 Jul; 20(1):93. PubMed ID: 37507692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-based versus high-risk strategies for the prevention of cardiovascular diseases in low- and middle-income countries.
    Babu RB; Alam M; Helis E; Fodor JG
    Indian Heart J; 2012; 64(5):439-43. PubMed ID: 23102379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global variation in the relative burden of stroke and ischemic heart disease.
    Kim AS; Johnston SC
    Circulation; 2011 Jul; 124(3):314-23. PubMed ID: 21730306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed-dose combination therapy to reduce the growing burden of cardiovascular disease in low- and middle-income countries: feasibility and challenges.
    Nansseu JR; Tankeu AT; Kamtchum-Tatuene J; Noubiap JJ
    J Clin Hypertens (Greenwich); 2018 Jan; 20(1):168-173. PubMed ID: 29316126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost of Utilising Maternal Health Services in Low- and Middle-Income Countries: A Systematic Review.
    Banke-Thomas A; Ayomoh FI; Abejirinde IO; Banke-Thomas O; Eboreime EA; Ameh CA
    Int J Health Policy Manag; 2021 Sep; 10(9):564-577. PubMed ID: 32610819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.
    Khatib R; McKee M; Shannon H; Chow C; Rangarajan S; Teo K; Wei L; Mony P; Mohan V; Gupta R; Kumar R; Vijayakumar K; Lear SA; Diaz R; Avezum A; Lopez-Jaramillo P; Lanas F; Yusoff K; Ismail N; Kazmi K; Rahman O; Rosengren A; Monsef N; Kelishadi R; Kruger A; Puoane T; Szuba A; Chifamba J; Temizhan A; Dagenais G; Gafni A; Yusuf S;
    Lancet; 2016 Jan; 387(10013):61-9. PubMed ID: 26498706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost of stroke in low and middle income countries: a systematic review.
    Kaur P; Kwatra G; Kaur R; Pandian JD
    Int J Stroke; 2014 Aug; 9(6):678-82. PubMed ID: 25041736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of simulation models for the long-term management of type 2 diabetes in low-and-middle income countries.
    Mukonda E; Cleary S; Lesosky M
    BMC Health Serv Res; 2021 Dec; 21(1):1313. PubMed ID: 34872555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time Trends in Cardiovascular Disease Mortality Across the BRICS: An Age-Period-Cohort Analysis of Key Nations With Emerging Economies Using the Global Burden of Disease Study 2017.
    Zou Z; Cini K; Dong B; Ma Y; Ma J; Burgner DP; Patton GC
    Circulation; 2020 Mar; 141(10):790-799. PubMed ID: 31941371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular diseases and diabetes as economic and developmental challenges in Africa.
    Kengne AP; June-Rose McHiza Z; Amoah AG; Mbanya JC
    Prog Cardiovasc Dis; 2013; 56(3):302-13. PubMed ID: 24267437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Economic Cost of Violence Against Women and Girls in Low- and Middle-Income Countries: A Systematic Review of the Evidence.
    Vyas S; Meinhart M; Troy K; Brumbaum H; Poulton C; Stark L
    Trauma Violence Abuse; 2023 Jan; 24(1):44-55. PubMed ID: 33998339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.